These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Pneumococcal infections: penicillin resistance and therapeutic implications]. Kamoun A; Ben Hassen A; Mahjoubi F; Ben Redjeb S Tunis Med; 1995 Feb; 73(2):119-23. PubMed ID: 9506153 [No Abstract] [Full Text] [Related]
26. Streptococcus pneumoniae: epidemiology and patterns of resistance. Jacobs MR Am J Med; 2004 Aug; 117 Suppl 3A():3S-15S. PubMed ID: 15360092 [TBL] [Abstract][Full Text] [Related]
27. Therapy for pneumococcal infection at the millennium: doubts and certainties. Ball P Am J Med; 1999 Jul; 107(1A):77S-85S. PubMed ID: 10451013 [TBL] [Abstract][Full Text] [Related]
29. Importance of dose and duration of beta-lactam therapy in nasopharyngeal colonization with resistant pneumococci. Canet JJ; Garau J J Antimicrob Chemother; 2002 Dec; 50 Suppl S2():39-43. PubMed ID: 12556432 [TBL] [Abstract][Full Text] [Related]
30. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance]. Bédos JP; Bruneel F Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956 [TBL] [Abstract][Full Text] [Related]
31. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. Friedland IR; McCracken GH N Engl J Med; 1994 Aug; 331(6):377-82. PubMed ID: 8028618 [TBL] [Abstract][Full Text] [Related]
32. Antibiotic resistance in pathogenic Streptococcus pneumoniae isolates in Turkey. Erdem H; Pahsa A J Chemother; 2005 Feb; 17(1):25-30. PubMed ID: 15828440 [TBL] [Abstract][Full Text] [Related]
33. [Antibacterial therapy of pneumococcal infections caused by drug resistant microorganisms]. Sidorenko SV Antibiot Khimioter; 2002; 47(7):31-7. PubMed ID: 12516194 [No Abstract] [Full Text] [Related]
34. [Clinical and bacteriological studies of Streptococcus pneumoniae. Yearly changes in isolation frequencies from clinical specimens, serotype distributions and drug susceptibilities, especially those of beta-lactam-resistant strains]. Oguri T Jpn J Antibiot; 1986 Mar; 39(3):783-806. PubMed ID: 3735669 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private paediatric practices in Johannesburg. Huebner RE; Wasas AD; Klugman KP; S Afr Med J; 2000 Nov; 90(11):1116-21. PubMed ID: 11196033 [TBL] [Abstract][Full Text] [Related]
36. An alarmingly high nasal carriage rate of Streptococcus pneumoniae serotype 19F non-susceptible to multiple beta-lactam antimicrobials among Vietnamese children. Nguyen HAT; Fujii H; Vu HTT; Parry CM; Dang AD; Ariyoshi K; Yoshida LM BMC Infect Dis; 2019 Mar; 19(1):241. PubMed ID: 30866853 [TBL] [Abstract][Full Text] [Related]
37. Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Baquero F Microb Drug Resist; 1995; 1(2):115-20. PubMed ID: 9158743 [TBL] [Abstract][Full Text] [Related]